Clinical Trial Detail

NCT ID NCT02667886
Title Trial of X4P-001 in Patients With Advanced Renal Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors X4 Pharmaceuticals
Indications

clear cell renal cell carcinoma

Therapies

Axitinib

X4P-001

Age Groups: adult

No variant requirements are available.